Atheln, Inc.

Preclinical Development > DMPK

Atheln is a contract development team supporting biopharma companies and investors in all phases of development and across all major classes and therapeutic areas. Atheln integrates technical, regulatory, and commercial needs to mitigate risk and maximize client success. Expertise includes nonclinical, CMC, quality, regulatory, clinical, product strategy, business development, and market access/reimbursement.

Contact

Adriana Manzi Managing Director Phone: 858-554-0636
Monica Alfaro Welling Managing Director Phone: 310-220-4332
www.athelnbiomed.com
6051 Scripps Street San Diego, CA 92122 USA